Want to see HK:8622 full AI Analyst Report?

Huakang Biomedical Holdings Company Limited (8622) Revenue

0 Followers

Huakang Biomedical Holdings Company Limited Revenue

Huakang Biomedical Holdings Company Limited had a revenue of 8.28M in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 32.51M, Decreased 6.95%. In the fiscal year ending Dec 31, 2025, Huakang Biomedical Holdings Company Limited had annual revenue of 28.28M with 11.53% growth.

Revenue (ttm)

32.51M

Revenue Growth

30.60%

P/S Ratio

3.15

Revenue/Employee

HK$280,020

Employees

101

Market Cap

HK$89.18M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	28.28M	2.92M	+11.53%
Dec 31, 2024	25.36M	730.00K	+2.96%
Dec 31, 2023	24.63M	-701.00K	-2.77%
Dec 31, 2022	25.33M	-797.00K	-3.05%
Dec 31, 2021	26.13M	4.16M	+18.94%
Dec 31, 2020	21.97M	-3.50M	-13.76%
Dec 31, 2019	25.47M	-3.21M	-11.18%
Dec 31, 2018	28.68M	2.14M	+8.05%
Dec 31, 2017	26.54M	―	―